↑ 薬物リストへ　← 戻る

Brivaracetam 50 mg    (DrugBank: Brivaracetam)

2 diseases
告示番号疾患名（ページ内リンク）臨床試験数
149片側痙攣・片麻痺・てんかん症候群0
309進行性ミオクローヌスてんかん1

149. 片側痙攣・片麻痺・てんかん症候群　［臨床試験数：22，薬物数：33（DrugBank：12），標的遺伝子数：13，標的パスウェイ数：17］
Searched query = "Hemiconvulsion hemiplegia epilepsy syndrome", "One side convulsions", "Hemiplegia", "Epilepsy syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 22 trial found

309. 進行性ミオクローヌスてんかん　［臨床試験数：11，薬物数：15（DrugBank：2），標的遺伝子数：4，標的パスウェイ数：9］
Searched query = "Progressive myoclonus epilepsy", "Unverricht-Lundborg disease", "Lafora disease", "Benign adult familial myoclonus epilepsy", "BAFME"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 11 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00357669
(ClinicalTrials.gov)		November 200625/7/2006Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and AdultsA Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment for 12 Weeks in Adolescent and Adult Patients (=16 Years) With Genetically Ascertained Unverricht-Lundborg DiseaseUnverricht-Lundborg DiseaseDrug: Brivaracetam 25 mg;Drug: Brivaracetam 50 mg;Other: PlaceboUCB Pharma SANULLCompleted16 YearsN/ABoth50Phase 3Finland;France;Italy;Netherlands;Réunion;Sweden;Tunisia